+1 347 708 0418
The Type-1 Diabetes Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Type-1 Diabetes Treatment size is estimated to be USD 6114.3 million in 2026 from USD 5165.4 million in 2020, with a change XX% between 2020 and 2021. The global Type-1 Diabetes Treatment market size is expected to grow at a CAGR of 4.3% for the next five years.
Market segmentation
Type-1 Diabetes Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rapid-Acting Insulin
Short-Acting Insulin
Others
Market segment by Application, can be divided into
Hospitals & Clinics
Academic & Research Institutes
Market segment by players, this report covers
Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Type-1 Diabetes Treatment
1.2 Classification of Type-1 Diabetes Treatment by Type
1.2.1 Overview: Global Type-1 Diabetes Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Type-1 Diabetes Treatment Revenue Market Share by Type in 2020
1.2.3 Rapid-Acting Insulin
1.2.4 Short-Acting Insulin
1.2.5 Others
1.3 Global Type-1 Diabetes Treatment Market by Application
1.3.1 Overview: Global Type-1 Diabetes Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Global Type-1 Diabetes Treatment Market Size & Forecast
1.5 Global Type-1 Diabetes Treatment Market Size and Forecast by Region
1.5.1 Global Type-1 Diabetes Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Type-1 Diabetes Treatment Market Size by Region, (2016-2021)
1.5.3 North America Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Type-1 Diabetes Treatment Market Drivers
1.6.2 Type-1 Diabetes Treatment Market Restraints
1.6.3 Type-1 Diabetes Treatment Trends Analysis
2 Company Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Type-1 Diabetes Treatment Product and Solutions
2.1.4 Astellas Pharma Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astellas Pharma Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Type-1 Diabetes Treatment Product and Solutions
2.2.4 Merck Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Type-1 Diabetes Treatment Product and Solutions
2.3.4 Eli Lilly Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Type-1 Diabetes Treatment Product and Solutions
2.4.4 Novo Nordisk Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novo Nordisk Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Type-1 Diabetes Treatment Product and Solutions
2.5.4 Sanofi Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Type-1 Diabetes Treatment Product and Solutions
2.6.4 AstraZeneca Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Boehringer Ingelheim GmbH
2.7.1 Boehringer Ingelheim GmbH Details
2.7.2 Boehringer Ingelheim GmbH Major Business
2.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product and Solutions
2.7.4 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Type-1 Diabetes Treatment Product and Solutions
2.8.4 Novartis Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Novartis Recent Developments and Future Plans
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Type-1 Diabetes Treatment Product and Solutions
2.9.4 Pfizer Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Inc. Recent Developments and Future Plans
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business
2.10.3 Abbott Laboratories Type-1 Diabetes Treatment Product and Solutions
2.10.4 Abbott Laboratories Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Abbott Laboratories Recent Developments and Future Plans
2.11 Mannkind Corporation
2.11.1 Mannkind Corporation Details
2.11.2 Mannkind Corporation Major Business
2.11.3 Mannkind Corporation Type-1 Diabetes Treatment Product and Solutions
2.11.4 Mannkind Corporation Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Mannkind Corporation Recent Developments and Future Plans
2.12 Braun Melsungen AG
2.12.1 Braun Melsungen AG Details
2.12.2 Braun Melsungen AG Major Business
2.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Product and Solutions
2.12.4 Braun Melsungen AG Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Braun Melsungen AG Recent Developments and Future Plans
2.13 Macrogenics, Inc.
2.13.1 Macrogenics, Inc. Details
2.13.2 Macrogenics, Inc. Major Business
2.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Product and Solutions
2.13.4 Macrogenics, Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Macrogenics, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Type-1 Diabetes Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Type-1 Diabetes Treatment Players Market Share
3.2.2 Top 10 Type-1 Diabetes Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Type-1 Diabetes Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Type-1 Diabetes Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Type-1 Diabetes Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Type-1 Diabetes Treatment Revenue Market Share by Application (2016-2021)
5.2 Type-1 Diabetes Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Type-1 Diabetes Treatment Revenue by Type (2016-2026)
6.2 North America Type-1 Diabetes Treatment Revenue by Application (2016-2026)
6.3 North America Type-1 Diabetes Treatment Market Size by Country
6.3.1 North America Type-1 Diabetes Treatment Revenue by Country (2016-2026)
6.3.2 United States Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Type-1 Diabetes Treatment Revenue by Type (2016-2026)
7.2 Europe Type-1 Diabetes Treatment Revenue by Application (2016-2026)
7.3 Europe Type-1 Diabetes Treatment Market Size by Country
7.3.1 Europe Type-1 Diabetes Treatment Revenue by Country (2016-2026)
7.3.2 Germany Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
7.3.3 France Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Type-1 Diabetes Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Type-1 Diabetes Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region
8.3.1 Asia-Pacific Type-1 Diabetes Treatment Revenue by Region (2016-2026)
8.3.2 China Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
8.3.5 India Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Type-1 Diabetes Treatment Revenue by Type (2016-2026)
9.2 South America Type-1 Diabetes Treatment Revenue by Application (2016-2026)
9.3 South America Type-1 Diabetes Treatment Market Size by Country
9.3.1 South America Type-1 Diabetes Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Type-1 Diabetes Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Type-1 Diabetes Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country
10.3.1 Middle East & Africa Type-1 Diabetes Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Type-1 Diabetes Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Type-1 Diabetes Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Type-1 Diabetes Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Type-1 Diabetes Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Type-1 Diabetes Treatment Revenue Market Share by Region (2021-2026)
Table 6. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Astellas Pharma Major Business
Table 8. Astellas Pharma Type-1 Diabetes Treatment Product and Solutions
Table 9. Astellas Pharma Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Type-1 Diabetes Treatment Product and Solutions
Table 13. Merck Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly Major Business
Table 16. Eli Lilly Type-1 Diabetes Treatment Product and Solutions
Table 17. Eli Lilly Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 19. Novo Nordisk Major Business
Table 20. Novo Nordisk Type-1 Diabetes Treatment Product and Solutions
Table 21. Novo Nordisk Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi Type-1 Diabetes Treatment Product and Solutions
Table 25. Sanofi Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 27. AstraZeneca Major Business
Table 28. AstraZeneca Type-1 Diabetes Treatment Product and Solutions
Table 29. AstraZeneca Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors
Table 31. Boehringer Ingelheim GmbH Major Business
Table 32. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product and Solutions
Table 33. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Novartis Corporate Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Type-1 Diabetes Treatment Product and Solutions
Table 37. Novartis Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Inc. Major Business
Table 40. Pfizer Inc. Type-1 Diabetes Treatment Product and Solutions
Table 41. Pfizer Inc. Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 43. Abbott Laboratories Major Business
Table 44. Abbott Laboratories Type-1 Diabetes Treatment Product and Solutions
Table 45. Abbott Laboratories Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Mannkind Corporation Corporate Information, Head Office, and Major Competitors
Table 47. Mannkind Corporation Major Business
Table 48. Mannkind Corporation Type-1 Diabetes Treatment Product and Solutions
Table 49. Mannkind Corporation Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Braun Melsungen AG Corporate Information, Head Office, and Major Competitors
Table 51. Braun Melsungen AG Major Business
Table 52. Braun Melsungen AG Type-1 Diabetes Treatment Product and Solutions
Table 53. Braun Melsungen AG Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Macrogenics, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Macrogenics, Inc. Major Business
Table 56. Macrogenics, Inc. Type-1 Diabetes Treatment Product and Solutions
Table 57. Macrogenics, Inc. Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Type-1 Diabetes Treatment Revenue (USD Million) by Players (2019-2021)
Table 59. Global Type-1 Diabetes Treatment Revenue Share by Players (2019-2021)
Table 60. Breakdown of Type-1 Diabetes Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Type-1 Diabetes Treatment Players Head Office, Products and Services Provided
Table 62. Type-1 Diabetes Treatment Mergers & Acquisitions in the Past Five Years
Table 63. Type-1 Diabetes Treatment New Entrants and Expansion Plans
Table 64. Global Type-1 Diabetes Treatment Revenue (USD Million) by Type (2016-2021)
Table 65. Global Type-1 Diabetes Treatment Revenue Share by Type (2016-2021)
Table 66. Global Type-1 Diabetes Treatment Revenue Forecast by Type (2021-2026)
Table 67. Global Type-1 Diabetes Treatment Revenue by Application (2016-2021)
Table 68. Global Type-1 Diabetes Treatment Revenue Forecast by Application (2021-2026)
Table 69. North America Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Type-1 Diabetes Treatment Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Type-1 Diabetes Treatment Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Type-1 Diabetes Treatment Picture
Figure 2. Global Type-1 Diabetes Treatment Revenue Market Share by Type in 2020
Figure 3. Rapid-Acting Insulin
Figure 4. Short-Acting Insulin
Figure 5. Others
Figure 6. Type-1 Diabetes Treatment Revenue Market Share by Application in 2020
Figure 7. Hospitals & Clinics Picture
Figure 8. Academic & Research Institutes Picture
Figure 9. Global Type-1 Diabetes Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Type-1 Diabetes Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Type-1 Diabetes Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Type-1 Diabetes Treatment Revenue Market Share by Region in 2020
Figure 13. North America Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Type-1 Diabetes Treatment Market Drivers
Figure 19. Type-1 Diabetes Treatment Market Restraints
Figure 20. Type-1 Diabetes Treatment Market Trends
Figure 21. Astellas Pharma Recent Developments and Future Plans
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Eli Lilly Recent Developments and Future Plans
Figure 24. Novo Nordisk Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. AstraZeneca Recent Developments and Future Plans
Figure 27. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Pfizer Inc. Recent Developments and Future Plans
Figure 30. Abbott Laboratories Recent Developments and Future Plans
Figure 31. Mannkind Corporation Recent Developments and Future Plans
Figure 32. Braun Melsungen AG Recent Developments and Future Plans
Figure 33. Macrogenics, Inc. Recent Developments and Future Plans
Figure 34. Global Type-1 Diabetes Treatment Revenue Share by Players in 2020
Figure 35. Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Type-1 Diabetes Treatment Revenue Market Share in 2020
Figure 37. Global Top 10 Players Type-1 Diabetes Treatment Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Type-1 Diabetes Treatment Revenue Share by Type in 2020
Figure 40. Global Type-1 Diabetes Treatment Market Share Forecast by Type (2021-2026)
Figure 41. Global Type-1 Diabetes Treatment Revenue Share by Application in 2020
Figure 42. Global Type-1 Diabetes Treatment Market Share Forecast by Application (2021-2026)
Figure 43. North America Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)
Figure 44. North America Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)
Figure 45. North America Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)
Figure 46. United States Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)
Figure 50. Europe Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)
Figure 51. Europe Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)
Figure 52. Germany Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Type-1 Diabetes Treatment Revenue Market Share by Region (2016-2026)
Figure 60. China Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)
Figure 67. South America Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)
Figure 68. South America Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Buy
